New Delhi, Jan. 12 -- In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anti-cancer drug nivolumab i... Read More
New Delhi, Jan. 12 -- In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anti-cancer drug nivolumab i... Read More
New Delhi, Jan. 6 -- New Delhi, Mumbai : Hyderabad-based Natco Pharma Ltd has filed a patent revocation petition before the Delhi high court against Danish drugmaker Novo Nordisk, which sells weight... Read More
New Delhi, Dec. 12 -- The Delhi High Court's division bench on Friday declined to stay a single-judge order that allows Indian drugmaker Dr Reddy's Laboratories to domestically manufacture and export ... Read More
New Delhi, Dec. 11 -- Danish drugmaker Novo Nordisk has moved the Delhi High Court's division bench seeking to restrain Dr Reddy's Laboratories from domestically manufacturing and exporting semaglutid... Read More
New Delhi, Dec. 11 -- Danish drugmaker Novo Nordisk has moved Delhi High Court's division bench seeking to restrain Dr. Reddy's Laboratories from domestically manufacturing and exporting semaglutide-t... Read More
New Delhi, Dec. 9 -- As blockbuster weight loss drug semaglutide inches closer to losing its patent exclusivity in India, innovator Novo Nordisk is upping its ante against local firms wanting to launc... Read More
New Delhi, Dec. 9 -- As blockbuster weight loss drug semaglutide inches closer to losing its patent exclusivity in India, innovator Novo Nordisk is upping its ante against local firms wanting to launc... Read More
New Delhi, Dec. 2 -- The Delhi High Court on Tuesday allowed domestic drugmaker Dr Reddy's Laboratories to manufacture and export its generic version of semaglutide to countries where the patent-holde... Read More